For years, Genome Technology has been poking at the good people of GE Healthcare to let us in on their plans for next-gen sequencing. Now, it seems, the muzzle is off.
In a post on the company's "From Edison's Desk" blog, John Nelson -- best known in this field as one of the minds behind TempliPhi -- writes about his team's work developing a next-gen sequencing platform. After a discussion of how the technology works, Nelson adds, "And yes, if you were wondering whether we are thinking of winning the X-Prize some day using this method, we do hope to. But that's a long way off just now."
Hmm. Do we buy it? GTO wouldn't be surprised if they're closer than they let on.